Effectiveness Registry to Study Therapies for Arthritis and Inflammatory Conditions: The Corrona CERTAIN Sub-study
NCT01625650 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2795
Last updated 2018-08-22
Summary
The CORRONA CERTAIN Sub-study of the Consortium of Rheumatology Researchers of North America, Inc. is a Sub-study of the CORRONA Data Collection Program.
The CERTAIN Sub-study is designed to systematically collect and document use patterns, effectiveness, comparative effectiveness and safety of biologic agents used in the management of Rheumatoid Arthritis (RA).
Conditions
Sponsors & Collaborators
-
University of Alabama at Birmingham
collaborator OTHER -
CorEvitas
lead NETWORK
Principal Investigators
-
Dimitrios Pappas, MD, MPH · CORRONA INC.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2015-05-31
- Completion
- 2015-05-31
Countries
- United States
Study Locations
More Related Trials
-
Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF
NCT02804204 ·Status: UNKNOWN
-
The Corrona Psoriatic Arthritis and Spondyloarthritis (PsA-SpA) Registry
NCT02530268 ·Status: ENROLLING_BY_INVITATION
-
Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis.
NCT01172639 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis
NCT00976599 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
NCT01211678 ·Status: COMPLETED
-
Biomarkers in Chronic Arthritis
NCT02909998 ·Status: COMPLETED
-
Rheumatology Clinical Registry
NCT01813409 ·Status: UNKNOWN
-
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
NCT02115750 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA
NCT03172325 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of the Clinical and Medico-economic Impact of SinnoTest® in Patients With Rheumatoid Arthritis
NCT04117165 ·Status: WITHDRAWN ·Phase: NA
-
Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
NCT00796705 ·Status: TERMINATED ·Phase: PHASE4
-
Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)
NCT01146652 ·Status: COMPLETED ·Phase: PHASE3
-
Survivin as Predictive Biomarker for RA
NCT03444623 ·Status: UNKNOWN
-
Brigham and Women's Rheumatoid Arthritis Sequential Study
NCT01793103 ·Status: ACTIVE_NOT_RECRUITING
-
COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA
NCT03649061 ·Status: COMPLETED ·Phase: PHASE4
-
Good EULAR Response In Patients With Early Rheumatoid Arthritis
NCT01558089 ·Status: COMPLETED
-
Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)
NCT00115219 ·Status: COMPLETED ·Phase: PHASE4
-
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"
NCT02878161 ·Status: UNKNOWN ·Phase: PHASE4
-
Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis
NCT00267852 ·Status: COMPLETED
-
Disease-Modifying Antirheumatic Drugs Cycle Combination Therapy Research
NCT01617590 ·Status: UNKNOWN ·Phase: NA
-
An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.
NCT02590562 ·Status: COMPLETED
-
Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate
NCT01783015 ·Status: TERMINATED ·Phase: PHASE4
-
Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
NCT04428424 ·Status: COMPLETED
-
Cross-validation of a Predictive Model of Response to Anti-TNF Alpha Based on Oxylipin Response in Rheumatoid Arthritis
NCT06880146 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Relation of IL23R and IL17A Gene Polymorphisms Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis Susceptibility and Activity
NCT05570513 ·Status: NOT_YET_RECRUITING